AI assistant
ABEONA THERAPEUTICS INC. — Director's Dealing 2021
Feb 10, 2021
33413_dirs_2021-02-10_7ab020a1-836f-49d1-b6ab-b15462652a0a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABEONA THERAPEUTICS INC. (ABEO)
CIK: 0000318306
Period of Report: 2021-02-08
Reporting Person: SCO CAPITAL PARTNERS LLC (Director, 10% Owner)
Reporting Person: Rouhandeh Steven H (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-08 | Common Stock | S | 240000 | $3.0118 | Disposed | 11359292 | Indirect |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by SCO Capital Partners LLC on July 13, 2020.
F2: The price reported in Column 4 is a weighted average price. The shares were
sold in multiple transactions at prices ranging from $3.00 to $3.06, inclusive. The
Reporting Person undertakes to provide to the Issuer, any security holder, or the
Staff of the SEC, upon request, full information regarding the number of shares
disposed at each separate price within the ranges set forth in this footnote.